The HICCC's Cancer Epidemiology (CE) program focuses on etiologic research into the environmental, lifestyle, and genetic causes that lead to increased incidence, morbidity and mortality from cancer and to develop early biomarkers of disease. Our program focuses on three themes: 1) Molecular epidemiology: These studies broadly include the integration of data collected from biospecimens with epidemiologic data to understand cancer risk. These studies take advantage of over 14 cohorts actively being studied, many with biospecimens, and the long history of research in the CE Program using biomarkers at Columbia's HICCC; 2) Lifecourse epidemiology and timing of events: The role of exposures in key susceptible time periods are investigated using study designs that capture risk factor data from pre and postnatal and other vulnerable cancer susceptibility periods;and 3) Global Environmental Cohorts: We conduct large epidemiologic studies investigating the effects of environmental exposures locally and around the globe. In each of our three program theme areas, we have at least one new junior faculty member who has been successfully funded through either a K99 or K07 grant mechanism. We particularly highlight the research contributions made not just by one study but rather a collection of studies that demonstrate the strength of each theme Our study populations also allow our members to conduct hypothesis-driven research across multiple study populations including high-risk families and population-average individuals who reflect our local catchment We work closely with members from the clinical programs to make sure our research reflects the needs of our patient population. From a public health translational perspective, our global work already focuses on mitigating risk in communities that are highly exposed. The CE Program consists of 20 members from three departments in the School of Public Health, two departments in the College of Physicians &Surgeons, and the School of Dental Medicine at Columbia University. The Program is supported by several large federally-funded collaborative grants including the Breast Cancer Family Registry, the NIEHS Center for Environmental Health in Northern Manhattan and a Superfund Basic Research Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-40
Application #
8753115
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2019-06-30
Budget Start
2014-07-17
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$66,637
Indirect Cost
$24,989
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Park, Karen Sophia; Tsang, Stephen H (2018) Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. Ophthalmic Genet 39:544-549
Wu, Wen-Hsuan; Tsai, Yi-Ting; Justus, Sally et al. (2018) CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods Mol Biol 1715:191-205
Ishida, Chiaki T; Zhang, Yiru; Bianchetti, Elena et al. (2018) Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. Clin Cancer Res 24:5392-5406
Yen, Bonnie; Fortson, Katherine T; Rothman, Nyanza J et al. (2018) Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. Immunohorizons 2:119-128
Renz, Bernhard W; Takahashi, Ryota; Tanaka, Takayuki et al. (2018) ?2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. Cancer Cell 33:75-90.e7
Jin, Chun-Hui; Li, Yang; Xia, Jinxing et al. (2018) CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion. Am J Hematol 93:786-793
Bakhoum, Mathieu F; Sengillo, Jesse D; Cui, Xuan et al. (2018) AUTOIMMUNE RETINOPATHY IN A PATIENT WITH A MISSENSE MUTATION IN PITPNM3. Retin Cases Brief Rep 12 Suppl 1:S72-S75
Velez, Gabriel; Tang, Peter H; Cabral, Thiago et al. (2018) Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease. Transl Vis Sci Technol 7:12
O'Neil, Daniel S; Prigerson, Holly G; Mmoledi, Keletso et al. (2018) Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage 56:98-106
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography. Sci Rep 8:13130

Showing the most recent 10 out of 331 publications